Table 5.
Analysis of the efficacy of IMA and BDNF and their combination for diagnosing CCH
| Serum marker | Cut-off value | AUC | 95% CI | p-value | Specificity | Sensitivity | Youden’s index | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Lower limit | Upper limit | |||||||
| IMA+BDNF | - | 0.803 | 0.708 | 0.898 | < 0.001 | 0.655 | 0.855 | 0.510 |
| IMA | 24.292 | 0.738 | 0.627 | 0.848 | < 0.001 | 0.621 | 0.836 | 0.457 |
| BDNF | 6.714 | 0.631 | 0.512 | 0.751 | 0.049 | 0.931 | 0.418 | 0.349 |
CCH: chronic cerebral hypoperfusion; BDNF: brain-derived neurotrophic factor; IMA: ischemia-modified albumin.